Compare MGYR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | ORMP |
|---|---|---|
| Founded | 1922 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 134.1M |
| IPO Year | 2006 | N/A |
| Metric | MGYR | ORMP |
|---|---|---|
| Price | $18.25 | $3.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7K | ★ 317.5K |
| Earning Date | 01-29-2026 | 03-26-2026 |
| Dividend Yield | 2.17% | ★ 7.33% |
| EPS Growth | 31.86 | ★ 838.25 |
| EPS | ★ 1.72 | 1.03 |
| Revenue | ★ $36,540,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.71 | ★ $3.32 |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $13.52 | $1.82 |
| 52 Week High | $19.04 | $3.71 |
| Indicator | MGYR | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.41 |
| Support Level | N/A | $3.24 |
| Resistance Level | N/A | $3.52 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 0.00 | 9.76 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.